Hydrogen-Releasing Microspheres Reduce Disc Degeneration in Rats
ROS-responsive magnesium-containing microspheres for antioxidative treatment of intervertebral disc degeneration
Research hubs: Musculoskeletal System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (rat)
- Authors
- Tianhui Zhang, Yongjie Wang, Ruhui Li, Jingguo Xin, Zhi Zheng, Xingmin Zhang, Chunsheng Xiao, Shaokun Zhang
- Journal
- Acta Biomaterialia
- Year
- 2023
- PMID
- 36640954
- Study Type
- Rat
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 61 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Scientists have created tiny, magnesium-based particles that release hydrogen to reduce harmful oxidative stress in spinal discs, showing promise for treating back pain caused by disc degeneration.
Key Finding
Magnesium-containing microspheres that generate hydrogen gas in response to oxidative stress reduced inflammation and prevented tissue breakdown in rats with intervertebral disc degeneration.
Summary
Researchers created tiny capsules containing magnesium that release hydrogen gas in response to harmful molecules (called reactive oxygen species or ROS) that accumulate in damaged spinal discs. In rats with spinal disc degeneration, these capsules reduced inflammation, slowed the breakdown of disc tissue, and preserved disc structure. The treatment appeared safe with no significant toxicity observed.
Practical Takeaway
This is early-stage research in animals only, so it cannot yet inform human use. While the results suggest hydrogen gas delivery via this novel capsule system may help protect spinal discs from oxidative damage, many steps of testing in humans would be needed before any clinical application. The study does not directly test hydrogen water or other forms of hydrogen that consumers might access.
Abstract (excerpt)
Intervertebral disc degeneration (IVDD) is a degenerative disease characterized by lower-back pain, causing disability globally. Antioxidant therapy is currently considered one of the most promising strategies for IVDD treatment, given the crucial role of reactive oxygen species (ROS) in IVDD…